ELEVANCE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Elevance Health, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Elevance Health, Inc. due to a class action lawsuit alleging that the company misled investors regarding the impact of Medicaid redetermination on its financial guidance and cost trends [1][2]. Group 1: Legal Investigation - The law firm is representing long-term stockholders of Elevance who held shares between April 18, 2024, and October 16, 2024, following a class action complaint filed on May 12, 2025 [1]. - The investigation focuses on whether Elevance's board of directors breached their fiduciary duties to the company [1]. Group 2: Allegations in the Lawsuit - The lawsuit claims that Elevance made false or misleading statements about its monitoring of cost trends related to the Medicaid redetermination process [2]. - It is alleged that while Elevance acknowledged rising Medicaid expenses, it misrepresented that these were adequately reflected in its financial guidance for 2024 [2]. - The lawsuit highlights that the redetermination process led to a significant increase in the acuity and utilization of Medicaid members, contrary to the company's assurances [2]. Group 3: Contact Information - Investors seeking more information or wishing to discuss their rights can contact Brandon Walker or Marion Passmore at Bragar Eagel & Squire, P.C. via phone or email [3][6].